CIDRAP newsletters options
Diagnostics company OpGen announced today that it has received 510(k) clearance from the US Food and Drug Administration (FDA) to market a new rapid molecular diagnostic tool that could aid in treating antibiotic-resistant or non-susceptible infections.
Reinfection from SARS-CoV-2 under endemic conditions will most likely occur at a median of 16 months, according to a modeling study published late last week in The Lancet Microbe.
Two studies assessed COVID-19 vaccine hesitancy in minorities and toward specific vaccine brands.
Also, Merck says its investigational oral antiviral drug reduces the risk of COVID-19 death by 50%.
One study highlights the fallout of unstable housing on Americans' mental and physical health.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
New antimicrobials to treat severe bacterial and fungal infections were among the drugs that the World Health Organization (WHO) included in its new Essential Medicines list, which is updated annually and serves as its recommended list of medicines that every health system should have.
Hospitalized COVID-19 patients who were treated with remdesivir within 2 days of admission had lower mortality rates than their matched cohort, according to a study today in Clinical Infectious Diseases. The observational cohort consisted of US adults hospitalized with COVID-19 from August to November 2020; 28,855 received remdesivir and 16,887 did not.
The 10-year plan starts today and gives recommendations for a range of scientific disciplines to better address seasonal flu and prepare for the next flu pandemic.
People in rural areas are currently twice as likely to die from COVID-19 as their urban peers, new data show.
Also, the monoclonal antibody combo resolved symptoms and reduced viral load faster than a placebo.
Critically ill COVID-19 patients who received extracorporeal membrane oxygenation (ECMO) at the end of 2020 had a higher mortality rate than those who received it in the first half of the year, according to a study published yesterday in The Lancet.
Results from a worldwide survey of hospitals suggests that the Global Point Prevalence Survey of Antimicrobial Consumption and Resistance (Global-PPS) has helped inform stewardship activities, Belgian researchers reported this week in Antimicrobial Resistance and Infection Control.
In a Chinese study, 45% had at least 1 persistent symptom after a year, and 16% had at least 3 symptoms.
Also, CDC data show similar side effects after a third Pfizer vaccine dose as seen after the second dose.
Cases and deaths continue to drop globally, but infections continue at very high levels.
An intervention based on the Centers for Disease Control and Prevention (CDC) Core Elements of Outpatient Antibiotic Stewardship yielded cost savings at 10 outpatient Veterans Healthcare Administration (VHA) sites, researchers reported today in Infection Control & Hospital Epidemiology.
Seven COVID-19 symptoms can maximize detection of COVID-19 in the community, according to a large study published in PLOS Medicine yesterday that looked at data from England's REal-time Assessment of Community Transmission-1 (REACT-1) study.
The data show that 1.2 million fewer people have been diagnosed and treated for TB in 2021 than in 2019.
Of the women, 8.14% used cannabis in spring 2020, compared with 6.75% before the pandemic.
